No takes yet. Share an insight, caveat, or question.
Analysis reveals disparities in imaging inspections and treatments for low-risk prostate cancer across different medical institutions in Japan.
Kobayashi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: